Mabpharm Limited's market cap is currently HK$2.60B. The company's EPS TTM is HK$0.001; its P/E ratio is ―; Mabpharm Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
